The study in the European Respiratory Journal used advanced spatial mapping techniques to compare healthy lung tissues and ...

A new research paper was published in Oncotarget, Volume 16, on March 21, 2025, titled “NSD2-epigenomic reprogramming and ...

Plasma cell leukemia (PCL) is a rare disease that may present de novoor secondary to plasma cell myeloma. Advanced disease and extramedullary involvement are common clinical features at presentation.

Plasma cells originate in lymphoid (immune) tissues and then migrate to protected sites throughout the body, where they ...

A growing number of physicians are starting to shift their thinking about multiple myeloma’s prognosis. For years, patients ...

A new research paper was published in , Volume 16, on March 21, 2025, titled "NSD2-epigenomic reprogramming and maintenance of plasma cell phenotype in t(4;14) myeloma." ...

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...

In this interview Prof. Dr. Kristina Kusche-Vihrog speaks about the nanomechanics of living cells and their implications for ...

Our findings suggest a role for NSD2 in maintaining MM cell identity, with potential implications for future therapeutic strategies based on ...

The researchers discovered that disease-scarred lung tissue abounds in plasma cells -- specialized immune cells that typically reside in bone marrow and produce antibodies. "What we found most ...